FDA clears EOS Micro Dose for pediatric imaging

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
 - FDA logo

EOS Imaging has received clearance from the Food and Drug Administration for its Micro Dose feature for pediatric imaging.

The EOS Imaging system is a low-dose 3-D imaging system that is able to scan children while they are standing up, allowing physicians to get a more accurate view of the spine and lower limbs.

According to EOS, initial results for Micro Dose show that it produces dose levels that are equivalent to a week’s worth of naturally occurring background radiation in pediatric patients receiving 2D and 3D follow up exams.

“The reduction of radiation exposure during orthopedic imaging exams remains a foremost concern among radiologists, orthopedic surgeons and patients,” said Marie Meynadier, CEO of EOS Imaging, in a statement. “The Micro Dose solution is a giant step forward and is in full accordance with the ALARA (As Low As Reasonably Achievable) principle.”